We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$53.4B
AUM Growth
+$3.95B
(+8%)
Cap. Flow
+$662M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
27.71%
Holding
4,164
New
242
Increased
1,490
Reduced
1,373
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$110M |
| 2 |
iShares Russell Mid-Cap ETF
IWR
|
+$101M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$95.7M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$78M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$54.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$28M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.9M |
| 3 |
US Bancorp
USB
|
+$25.2M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$24.6M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 9.18% |
| 3 | Healthcare | 8.48% |
| 4 | Industrials | 7.72% |
| 5 | Consumer Staples | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Arcosa
ACA
$7.14B
| $426K | ﹤0.01% |
7,254
-302
| -4% | -$18.7K |
|
1627
Cleveland-Cliffs
CLF
$6.83B
| $426K | ﹤0.01% |
19,758
+2,256
| +13% | +$44.5K |
|
1628
Tootsie Roll Industries
TR
$2.94B
| $426K | ﹤0.01% |
14,596
+1,427
| +11% | +$40.2K |
|
1629
Global X SuperDividend ETF
SDIV
$1.22B
| $424K | ﹤0.01% |
10,000
| – | – |
|
1630
Cullen/Frost Bankers
CFR
$10.5B
| $423K | ﹤0.01% |
3,779
+238
| +7% | +$27.8K |
|
1631
Inspire Medical Systems
INSP
$1.5B
| $423K | ﹤0.01% |
2,187
+151
| +7% | +$29.9K |
|
|
VMEO
1632
DELISTED
Vimeo
VMEO
| $423K | ﹤0.01% |
+8,640
| New | +$397K |
|
1633
BCE
BCE
$20.3B
| $422K | ﹤0.01% |
8,551
-2,090
| -20% | -$101K |
|
1634
CVB Financial
CVBF
$4.02B
| $422K | ﹤0.01% |
20,509
-2,991
| -13% | -$65.3K |
|
1635
Lloyds Banking Group
LYG
$87.4B
| $422K | ﹤0.01% |
165,450
-2,095
| -1% | -$5.38K |
|
1636
Encompass Health
EHC
$11.5B
| $421K | ﹤0.01% |
6,787
+258
| +4% | +$17.2K |
|
1637
ArcelorMittal
MT
$50.8B
| $421K | ﹤0.01% |
13,524
+1,057
| +8% | +$32.7K |
|
1638
Supernus Pharmaceuticals
SUPN
$2.77B
| $421K | ﹤0.01% |
13,685
+619
| +5% | +$19K |
|
|
BPMC
1639
DELISTED
Blueprint Medicines
BPMC
| $420K | ﹤0.01% |
4,769
+211
| +5% | +$19.3K |
|
1640
Stellantis
STLA
$16.7B
| $418K | ﹤0.01% |
21,245
+377
| +2% | +$7.09K |
|
1641
Western Midstream Partners
WES
$19.4B
| $418K | ﹤0.01% |
19,511
| – | – |
|
1642
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
| $416K | ﹤0.01% |
26,510
+343
| +1% | +$5.22K |
|
1643
Cognyte Software
CGNT
$658M
| $415K | ﹤0.01% |
16,907
-4,342
| -20% | -$107K |
|
1644
Stewart Information Services
STC
$2.12B
| $415K | ﹤0.01% |
7,321
+96
| +1% | +$5.6K |
|
|
NUO
1645
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
| $415K | ﹤0.01% |
25,350
+3,100
| +14% | +$49.9K |
|
1646
Broadway Financial
BYFC
$94.3M
| $413K | ﹤0.01% |
19,189
| – | – |
|
1647
Toll Brothers
TOL
$14.5B
| $413K | ﹤0.01% |
7,149
-237
| -3% | -$14.4K |
|
1648
Veracyte
VCYT
$4.44B
| $413K | ﹤0.01% |
10,305
+3,097
| +43% | +$132K |
|
1649
Autoliv
ALV
$9.09B
| $412K | ﹤0.01% |
4,213
-126
| -3% | -$12.7K |
|
1650
Royal Gold
RGLD
$16.6B
| $412K | ﹤0.01% |
3,615
+13
| +0.4% | +$1.53K |
|
Similar funds
US Bancorp's Q2 2021 Portfolio in Review
As of Q2 2021, US Bancorp held 4,164 positions worth $53.4B, up 8% from $49.4B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
US Bancorp's Q2 2021 filing shows 242 new, 1,490 increased, 1,373 reduced and 118 closed positions. Its largest new stake was Organon & Co: 165,056 shares worth $5M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $28M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- US Bancorp's largest Q2 2021 buy was Organon & Co: 165,056 shares worth $5M.
- US Bancorp added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $110M increase.
- US Bancorp's biggest Q2 2021 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $28M.
- US Bancorp fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $6.31M.
- US Bancorp's ten largest holdings make up 28% of its $53.4B portfolio in Q2 2021.
- US Bancorp opened 242 new positions and closed 118 in Q2 2021.
- US Bancorp's portfolio value rose 8% quarter-over-quarter to $53.4B.
Based on US Bancorp's 13F filing for Q2 2021, filed 5 Aug 2021.